Literature DB >> 1774622

Muscle microdialysis as a model study to relate the drug concentration in tissue interstitial fluid and dialysate.

Y Deguchi1, T Terasaki, S Kawasaki, A Tsuji.   

Abstract

The steady-state dialysis kinetics in buffer, erythrocyte suspension and muscle have been analyzed by clearance theory in the microdialysis study. "Tube" model has been demonstrated to be a useful model to relate the dialysis clearance, CLD, the dialysis flow rate, F, and the permeability rate constant, PA, for microdialysis employing the transcranial type microdialysis probe. The effective dialysis coefficient (Rd), defined as the ratio of the in vivo PA and in vitro PA, was introduced to account for the differences between in vivo and in vitro microdialyses. The Arrhenius plot of the antipyrine permeability rate constant presented a single straight line in the range of 15-37 degrees C with an activation energy of 5.49 kcal/mol. A fairly good correlation was observed between the reciprocal of the permeability rate constant and the root of the molecular weight in the range of 18-1039. On the contrary, the molecular weight and the plasma membrane permeability were not determinant factors for Rd value determined in the erythrocyte suspension (Rd,erythrocyte), while the interstitial fluid space (100-hematocrit)% of erythrocyte suspension plays a dominant factor to change Rd,erythrocyte. The in vivo permeability rate constant was determined in the muscle for [3H]water, [14C]urea, antipyrine and [14C]sucrose under the steady-state condition. No significant difference of Rd in muscle tissue was demonstrated for these four model substances. By using the Rd value, a hypothetical equation has been proposed to relate the concentration in the dialysate and the interstitial fluid at steady-state.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1774622     DOI: 10.1248/bpb1978.14.483

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  6 in total

Review 1.  Application of microdialysis in pharmacokinetic studies.

Authors:  W F Elmquist; R J Sawchuk
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

2.  Study on brain interstitial fluid distribution and blood-brain barrier transport of baclofen in rats by microdialysis.

Authors:  Y Deguchi; K Inabe; K Tomiyasu; K Nozawa; S Yamada; R Kimura
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

3.  Determination of free extracellular levels of methotrexate by microdialysis in muscle and solid tumor of the rabbit.

Authors:  S Dukic; M L Kaltenbach; B Gourdier; H Marty; R Vistelle
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

4.  Long-term calibration considerations during subcutaneous microdialysis sampling in mobile rats.

Authors:  Xiaodun Mou; Michelle R Lennartz; Daniel J Loegering; Julie A Stenken
Journal:  Biomaterials       Date:  2010-03-11       Impact factor: 12.479

5.  Pharmacodynamic modeling for change of locomotor activity by methylphenidate in rats.

Authors:  T Aoyama; K Yamamoto; H Kotaki; Y Sawada; T Iga
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

6.  Distribution of tacrine across the blood-brain barrier in awake, freely moving rats using in vivo microdialysis sampling.

Authors:  M Telting-Diaz; C E Lunte
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.